Book a Demo
Yeji Jesse Lee
Gray shield icon
Is this you?
Claim your profile.

Yeji Jesse Lee

Senior Healthcare Reporter

AS SEEN ON
Law360

Preston's Summary

Yeji Jesse Lee is a Senior Healthcare Reporter at Law360. She specializes in reporting on the intersection of healthcare with major corporations like Amazon and Walmart, providing insights into how these giants impact the industry. Yeji's work has been featured in notable publications including Business Insider and AOL, Inc.

Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston

Geo Focus

United States (National)

Coverage Attributes:

Beta
Promotional: 100 %

Themes Covered:

Not enough data icon

Not enough data

Most Recent Topics:

  • Amazon
  • Walmart

Pitching Insights

Yeji Jesse Lee's articles often focus on business and health-related topics, particularly those related to major retailers such as Amazon and Walmart. Her coverage includes a significant amount of data citations and press releases.

When reaching out to Yeji, consider offering pitches that involve data-driven analyses or access to exclusive industry information regarding the latest trends in retail, consumer behavior, or healthcare services provided by these companies. Additionally, providing insights into how new policies or initiatives may impact consumers' health or businesses can be valuable for her coverage.

It seems that Yeji doesn't have a specific geographic focus but rather covers national and international stories related to major retail chains like Amazon and Walmart.

This information evolves through artificial intelligence and human feedback. Improve this profile .

Articles

Law360

RFK Jr. To Target 'Overmedicalization' Of Mental Health Drugs

RFK Jr. To Target 'Overmedicalization' Of Mental Health Drugs

By: Yeji Jesse Lee

Health Secretary Robert F. Kennedy Jr. announced that the U.S. Department of Health and Human Services is moving to tackle the "overmedicalization" of widely used mental health drugs and create pathways to encourage doctors to taper patients off of the treatments.

© 2026 Intelligent Relations